The Eplontersen Pregnancy and Lactation Outcomes Study
NCT07205666 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2026-05-01
Summary
The overall objective of this DPSS is to describe the occurrence of pregnancy and maternal complications, adverse effects on the developing fetus and neonate, and adverse effects on the infant associated with exposure to eplontersen during pregnancy and/or lactation.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Myriam Alexander, PHD · AstraZeneca
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-30
- Primary Completion
- 2035-12-30
- Completion
- 2035-12-30
Countries
- Germany
Study Locations
More Related Trials
-
Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia
NCT00719537 ·Status: TERMINATED ·Phase: NA
-
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
NCT03528967 ·Status: COMPLETED ·Phase: PHASE4
-
MR and Inflammation After Preeclampsia
NCT07345845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study
NCT03379558 ·Status: TERMINATED
-
Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
NCT04558268 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Treatment With Aspirin After Preeclampsia: TAP Trial
NCT06281665 ·Status: RECRUITING ·Phase: PHASE4
-
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
NCT04063397 ·Status: COMPLETED
-
Losartan for Improved Vascular Endothelial Function After Preeclampsia
NCT04632589 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effectiveness of Aspirin on Preventing Pre-eclampsia
NCT04656665 ·Status: UNKNOWN ·Phase: PHASE4
-
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
NCT03100123 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Obstetric Antiphospholipid Antibody Syndrome : Contribution of the Evaluation of ADAMTS13 Made at the Diagnosis of Pregnancy on Evaluation the Risk of Pre-eclampsia
NCT04319341 ·Status: COMPLETED
-
Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.
NCT04846686 ·Status: COMPLETED
-
Characterization and Epigenetics of Post-Partum Preeclampsia
NCT02935556 ·Status: TERMINATED
-
Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia
NCT07327255 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy
NCT01388322 ·Status: COMPLETED ·Phase: PHASE3
-
Promacta Pregnancy Registry
NCT01064336 ·Status: COMPLETED
-
The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy Outcome
NCT04275622 ·Status: UNKNOWN ·Phase: NA
-
Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
NCT00116272 ·Status: COMPLETED
-
Cardiovascular Protection After Preeclampsia With Enalapril
NCT07222852 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Anifrolumab PRIM Program
NCT06795893 ·Status: RECRUITING
-
Oxford Luteal Dysfunction and Placental Insufficiency Study
NCT07072052 ·Status: NOT_YET_RECRUITING
-
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
NCT06531525 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
NCT04274803 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
NCT01566630 ·Status: TERMINATED ·Phase: PHASE2
-
Oral Prophylactic Measures on the Occurrence of Pre-eclampsia (OP-PE)
NCT04989075 ·Status: COMPLETED ·Phase: NA